Gaskiyar Game da Iron Overload

Iron Overload Zai iya kaiwa zuwa Hemochromatosis

A matsayin mata, ana tunatar da mu game da buƙatar mu na musamman na baƙin ƙarfe, saboda haka ƙarfewar baƙin ƙarfe na iya zama kamar na ƙarshe da muke bukata muyi la'akari. Ga mafi yawan mu, shi ne. Mata da yawa suna amfani da ƙarfe don haɗuwa da rata ba tare da matsala ba. Duk da haka, saboda fiye da miliyan 1 na Amirka, ƙarfin ƙarfe na iya samun sakamakon lalacewa.

Bisa ga Cibiyar Kula da Cututtuka (CDC), waɗannan mutane suna da maye gurbin maye gurbin wanda zai iya haifar da karfin ƙarfe, wanda zai haifar da hemochromatosis - cuta wanda zai haifar da lalacewa ta jiki saboda rashin ƙarfi da wuce kima da kuma ajiyar baƙin ƙarfe.

Mutanen Yammacin Turai suna iya zama cikin wannan haɗari.

Menene Iron Overload?

Sauyewar ƙarfe yana faruwa, bayan shekaru masu yawa, jiki yana karɓar ƙarfe mai ƙarfin ƙarfe wanda yake gina jiki a jikin kwayoyin halitta kamar zuciya da / ko hanta. Rikici na ƙarfe yana da mummunan yanayin da ya kamata a bincikar da shi yadda ya kamata. Matsalar ƙarfe ba tare da yin amfani da shi ba zai iya haifar da hemochromatosis, wanda shine barazana ga rayuwa.

Duk da yake mafi yawancin kwayoyin cutar hawan jini sune asalin asali, kamar yadda aka ambata, wasu mawuyacin kwayoyin halitta na iya zama zargi. Wadannan zasu iya haɗa da rikitarwa daga wasu cututtukan jini, ciwon magungunan transfusion na kullum, ciwon hawan hepatitis, da kuma cin nama mai tsanani.

Mene ne alamun kwayar cutar ƙarfe ko Hemochromatosis?

Duk da yake babu wani nau'i na bayyanar cututtuka da ke nuna alamar ƙarfe, farkon bayyanar cututtuka na baƙin ƙarfe ko hemochromatosis sun hada da:

Yayin da ake sauke nauyin ƙarfe, marasa lafiya sukan fuskanci:

Wasu sharuɗɗa suna haɗuwa da matakan ci gaba na hemochromatosis. Waɗannan sharuɗɗa sun haɗa da:

Wasu dalilai na iya rinjayar cigaban hemochromatosis. Wadannan dalilai sun hada da:

Ta Yaya Ironin Bincike na Iron yake?

Binciken gwada ƙarfin ƙarfe ko hemochromatosis da wuri yana da mahimmanci don kare yawancin cututtukan da ke tattare da rayuwa. Kodayake lokuttan binciken likita ba su haɗa da gwaji don ƙarfe ba, mai ganewa yana da sauƙi kamar yadda ake gudanar da gwaje-gwaje ta jiki mai sauƙi, marar tsada.

Ana buƙatar azumi don duka saturation da kwayar cutar jini. Idan kana da dangin dangin dangi wanda aka gano tare da hemochromatosis, tambayi ma'aikacin lafiyarka don gudanar da waɗannan gwagwarmaya masu sauki a yau.

Mene ne Maganin Gurasar Iron ko Magungunan Hemochromatosis?

Kwayar da aka fi so don rage matakan ƙarfe a cikin marasa lafiya na hemochromatosis ana kiransa phlebotomy.

Tsuntsu shine kawai cire jini daga jiki. Da farko, phlebotomy yana hana yawan lalacewar da aka haifar da baƙin ƙarfe.

Marasa lafiya waɗanda ba su da wata shaida game da nama ko lalata kwayoyin halitta lokacin da aka bincikar su suna iya tsammanin rayuwa da ta al'ada. Maganin da suka riga sun sami lalacewar jiki ko kuma nama zasu iya dakatar da cigaba da hemochromatosis kuma basu tsammanin babu wani lalacewa, raguwa da alamun cututtuka, da kuma inganta rayuwar rayuwa sau ɗaya lokacin farawa.

Hanyar da ake amfani da shi na yau da kullum ya shafi cire ɗaya daga cikin jini ɗaya sau ɗaya ko sau biyu a mako. Gwaran abu yana ci gaba har sai an cire duk abin baƙin ƙarfe. Matakan ƙarfe a cikin jini ana kulawa a ci gaba a cikin jiyya. Yawancin lokaci da maimaita jiyya yana da ƙarfin haƙuri, jinsi, dalili don ganewar asali, da kuma tsananin bayyanar cututtuka.

Da zarar an samo matakan ƙarfe na al'ada, yawancin phlebotomy zai iya rage zuwa sau uku ko sau hudu a kowace shekara bisa ga alamun bayyanar mutum da kuma matakan haemoglobin da kuma serritin serum.

Muhimmiyar Magana Game da Iron Matakan

Kada ku ɗauki kayan aikin ƙarfe ba tare da shawarwarin likitanku ba. Yawancin lokaci, za a bada shawara a bayan gwaje-gwaje na jini ya nuna cewa kai baƙin ƙarfe ne. Idan kun kasance a kan kari, tabbatar da samun matakan ƙarfe da haemoglobin da likitanku suka biyo baya.

Source:

Cibiyoyin Kula da Cututtuka - CDC. Hemochromotosis da Iron Overload. http://www.cdc.gov/ncbddd/hemochromatosis/.